In the BioHarmony Drug Report Database

"Preview" Icon

Estetrol

Nextstellis, Drovelis, Lydisilka (estetrol) is a small molecule pharmaceutical. Estetrol was first approved as Nextstellis on 2021-04-15. It has been approved in Europe to treat contraception. Nextstellis’s patent is valid until 2025-03-02 (FDA).

 

Trade Name

 

Drovelis, Lydisilka
 

Common Name

 

estetrol
 

ChEMBL ID

 

CHEMBL1230314
 

Indication

 

contraception
 

Drug Class

 

Image (chem structure or protein)

Estetrol structure rendering